Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	calcium ion binding	DCHS2 PADI4 CDH26 DGKA CDH23 ADGRV1 ADGRE2 DYSF ITPR3 ESYT2 NELL2 SULF2 HMCN2 OTOF SULF1 PCDHGB1 PCDHGA9 PLCD4 PCDHA5 SYT2 MYOF TGM3 PDP1 MACF1 PCDHGC3	3.26e-07	749	209	25	GO:0005509
GeneOntologyMolecularFunction	ATP hydrolysis activity	RTEL1 PEX1 ABCA10 IQCA1L MDN1 SHOC1 NAV1 DNAH8 HSPA2 HSPA8 ABCC10 ATP13A4 DNAH3 KIF16B ABCA6 MACF1	1.75e-05	441	209	16	GO:0016887
GeneOntologyMolecularFunction	ATP-dependent activity	RTEL1 TMEM94 PEX1 ABCA10 IQCA1L MDN1 SHOC1 NAV1 DNAH8 HSPA2 HSPA8 ABCC10 ATP13A4 DNAH3 KIF16B ABCA6 MACF1 MYO15A	8.60e-05	614	209	18	GO:0140657
GeneOntologyMolecularFunction	N-acetylglucosamine-6-sulfatase activity	SULF2 SULF1	3.25e-04	3	209	2	GO:0008449
GeneOntologyMolecularFunction	alkylglycerol kinase activity	DGKA DGKQ	3.25e-04	3	209	2	GO:0047649
GeneOntologyCellularComponent	extracellular matrix	TPSAB1 FREM2 SERPINB9 HMCN2 SULF1 ADAMTS16 SERPINF2 GP1BA FRAS1 VASN L1CAM LAMA4 LAMB3 FREM3 ITIH5 TGM3 ADAMTS14 TPSB2	1.12e-04	656	209	18	GO:0031012
GeneOntologyCellularComponent	external encapsulating structure	TPSAB1 FREM2 SERPINB9 HMCN2 SULF1 ADAMTS16 SERPINF2 GP1BA FRAS1 VASN L1CAM LAMA4 LAMB3 FREM3 ITIH5 TGM3 ADAMTS14 TPSB2	1.16e-04	658	209	18	GO:0030312
Domain	Calx_beta	ADGRV1 FREM2 FRAS1 FREM3	8.81e-07	8	201	4	SM00237
Domain	Calx_beta	ADGRV1 FREM2 FRAS1 FREM3	1.57e-06	9	201	4	IPR003644
Domain	Calx-beta	ADGRV1 FREM2 FRAS1 FREM3	1.57e-06	9	201	4	PF03160
Domain	Cadherin	DCHS2 CDH26 CDH23 FREM2 PCDHGB1 PCDHGA9 PCDHA5 FREM3 PCDHGC3	5.26e-06	118	201	9	IPR002126
Domain	FerI	DYSF OTOF MYOF	1.21e-05	5	201	3	SM01202
Domain	FerB	DYSF OTOF MYOF	1.21e-05	5	201	3	SM01201
Domain	Ferlin_B-domain	DYSF OTOF MYOF	1.21e-05	5	201	3	IPR012561
Domain	Ferlin_C	DYSF OTOF MYOF	1.21e-05	5	201	3	PF16165
Domain	Ferlin_C	DYSF OTOF MYOF	1.21e-05	5	201	3	IPR032362
Domain	FerIin_dom	DYSF OTOF MYOF	1.21e-05	5	201	3	IPR012968
Domain	FerI	DYSF OTOF MYOF	1.21e-05	5	201	3	PF08151
Domain	FerB	DYSF OTOF MYOF	1.21e-05	5	201	3	PF08150
Domain	CA	DCHS2 CDH26 CDH23 FREM2 PCDHGB1 PCDHGA9 PCDHA5 PCDHGC3	3.46e-05	115	201	8	SM00112
Domain	Extracellular_sulfatase	SULF2 SULF1	1.15e-04	2	201	2	IPR014615
Domain	Extracellular_sulfatase_C	SULF2 SULF1	1.15e-04	2	201	2	IPR024609
Domain	DUF3740	SULF2 SULF1	1.15e-04	2	201	2	PF12548
Domain	HEAT	UTP20 PPP4R1 SCYL3 PRKDC HTT	1.61e-04	48	201	5	PF02985
Domain	AAA	PEX1 ABCA10 MDN1 NAV1 DNAH8 ABCC10 DNAH3 ABCA6	1.69e-04	144	201	8	SM00382
Domain	AAA+_ATPase	PEX1 ABCA10 MDN1 NAV1 DNAH8 ABCC10 DNAH3 ABCA6	1.69e-04	144	201	8	IPR003593
Domain	Cadherin_CS	DCHS2 CDH26 CDH23 PCDHGB1 PCDHGA9 PCDHA5 PCDHGC3	1.78e-04	109	201	7	IPR020894
Domain	DHR-1_domain	DOCK5 DOCK8 DOCK7	1.90e-04	11	201	3	IPR027007
Domain	DHR_2	DOCK5 DOCK8 DOCK7	1.90e-04	11	201	3	PS51651
Domain	DHR_1	DOCK5 DOCK8 DOCK7	1.90e-04	11	201	3	PS51650
Domain	DHR-2	DOCK5 DOCK8 DOCK7	1.90e-04	11	201	3	PF06920
Domain	DOCK	DOCK5 DOCK8 DOCK7	1.90e-04	11	201	3	IPR026791
Domain	DOCK_C	DOCK5 DOCK8 DOCK7	1.90e-04	11	201	3	IPR010703
Domain	DOCK-C2	DOCK5 DOCK8 DOCK7	1.90e-04	11	201	3	PF14429
Domain	DHR-2	DOCK5 DOCK8 DOCK7	1.90e-04	11	201	3	IPR027357
Domain	-	DYSF C2CD2L ESYT2 OTOF PLCD4 SYT2 RAB11FIP1 MYOF	2.04e-04	148	201	8	2.60.40.150
Domain	CADHERIN_1	DCHS2 CDH26 CDH23 PCDHGB1 PCDHGA9 PCDHA5 PCDHGC3	2.22e-04	113	201	7	PS00232
Domain	Cadherin	DCHS2 CDH26 CDH23 PCDHGB1 PCDHGA9 PCDHA5 PCDHGC3	2.22e-04	113	201	7	PF00028
Domain	CADHERIN_2	DCHS2 CDH26 CDH23 PCDHGB1 PCDHGA9 PCDHA5 PCDHGC3	2.35e-04	114	201	7	PS50268
Domain	-	DCHS2 CDH26 CDH23 PCDHGB1 PCDHGA9 PCDHA5 PCDHGC3	2.35e-04	114	201	7	2.60.40.60
Domain	Cadherin-like	DCHS2 CDH26 CDH23 PCDHGB1 PCDHGA9 PCDHA5 PCDHGC3	2.61e-04	116	201	7	IPR015919
Domain	FerA	DYSF MYOF	3.43e-04	3	201	2	SM01200
Domain	Ferlin_A-domain	DYSF MYOF	3.43e-04	3	201	2	IPR012560
Domain	HDAC4_Gln	HDAC9 HDAC5	3.43e-04	3	201	2	PF12203
Domain	FerA	DYSF MYOF	3.43e-04	3	201	2	PF08165
Domain	Hist_deacetylase_Gln_rich_N	HDAC9 HDAC5	3.43e-04	3	201	2	IPR024643
Domain	Serpin_CS	SERPINB9 SERPINB10 SERPINF2 SERPINB2	3.70e-04	32	201	4	IPR023795
Domain	HEAT	UTP20 PPP4R1 SCYL3 PRKDC HTT	3.96e-04	58	201	5	IPR000357
Domain	C2_dom	DYSF C2CD2L ESYT2 OTOF PLCD4 SYT2 RAB11FIP1 MYOF	4.08e-04	164	201	8	IPR000008
Domain	ATPase_dyneun-rel_AAA	MDN1 DNAH8 DNAH3	4.10e-04	14	201	3	IPR011704
Domain	AAA_5	MDN1 DNAH8 DNAH3	4.10e-04	14	201	3	PF07728
Domain	C2	DYSF ESYT2 OTOF PLCD4 SYT2 RAB11FIP1 MYOF	5.46e-04	131	201	7	PF00168
Domain	Serpin_dom	SERPINB9 SERPINB10 SERPINF2 SERPINB2	5.86e-04	36	201	4	IPR023796
Domain	Cadherin_tail	PCDHGB1 PCDHGA9 PCDHA5 PCDHGC3	6.51e-04	37	201	4	PF15974
Domain	Cadherin_CBD	PCDHGB1 PCDHGA9 PCDHA5 PCDHGC3	6.51e-04	37	201	4	IPR031904
Domain	SERPIN	SERPINB9 SERPINB10 SERPINF2 SERPINB2	6.51e-04	37	201	4	PS00284
Domain	SERPIN	SERPINB9 SERPINB10 SERPINF2 SERPINB2	6.51e-04	37	201	4	SM00093
Domain	DysFC	DYSF MYOF	6.82e-04	4	201	2	SM00694
Domain	DysFN	DYSF MYOF	6.82e-04	4	201	2	SM00693
Domain	Histone_deAcase_II_euk	HDAC9 HDAC5	6.82e-04	4	201	2	IPR017320
Domain	Peroxin/Ferlin	DYSF MYOF	6.82e-04	4	201	2	IPR006614
Domain	KCL_cotranspt	SLC12A5 SLC12A6	6.82e-04	4	201	2	IPR000076
Domain	C2	DYSF ESYT2 OTOF PLCD4 SYT2 RAB11FIP1 MYOF	7.13e-04	137	201	7	SM00239
Domain	Serpin	SERPINB9 SERPINB10 SERPINF2 SERPINB2	7.22e-04	38	201	4	PF00079
Domain	Serpin_fam	SERPINB9 SERPINB10 SERPINF2 SERPINB2	7.97e-04	39	201	4	IPR000215
Domain	Laminin_G_2	CNTNAP3B CNTNAP3 NELL2 LAMA4	8.79e-04	40	201	4	PF02210
Domain	C2	DYSF ESYT2 OTOF PLCD4 SYT2 RAB11FIP1 MYOF	8.80e-04	142	201	7	PS50004
Domain	HEAT_REPEAT	UTP20 PPP4R1 SCYL3 PRKDC HTT	9.43e-04	70	201	5	PS50077
Domain	ARM-type_fold	DOCK5 NOC4L UTP20 PPP4R1 DOCK8 SCYL3 HUWE1 ARFGEF3 PRKDC NUP188 HTT	1.15e-03	339	201	11	IPR016024
Domain	LamG	CNTNAP3B CNTNAP3 NELL2 LAMA4	1.26e-03	44	201	4	SM00282
Domain	DUF3398	DOCK8 DOCK7	1.68e-03	6	201	2	PF11878
Domain	DOCK_C/D_N	DOCK8 DOCK7	1.68e-03	6	201	2	IPR021816
Domain	Pentatricopeptide_repeat	DENND4B PRKDC HTT	1.86e-03	23	201	3	IPR002885
Domain	SLC12A_fam	SLC12A5 SLC12A6	2.34e-03	7	201	2	IPR004842
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	TMEM94 DGKQ DYSF AHDC1 BAP1 ITPR3 C2CD2L KMT2C TNRC18 MDN1 EIF4ENIF1 NAV1 NLRC5 ABCC10 ENGASE FRAS1 SH3RF1 L1CAM KSR2 LAMB3 HUWE1 TFE3 KCNH3 MYOF ZNF500 ZFYVE26 PRKDC NUP188 HTT	3.04e-11	1105	209	29	35748872
Pubmed	Construction of expression-ready cDNA clones for KIAA genes: manual curation of 330 KIAA cDNA clones.	RTEL1 ADGRV1 BAP1 C2CD2L CEP68 KMT2C ESYT2 SULF2 DOP1B HDAC5 MYOF MACF1 AKAP11 GRIP2	1.10e-10	225	209	14	12168954
Pubmed	E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins.	DGKA DOCK5 KMT2C FREM2 MDN1 DENND4B UTP20 OR7A10 HSPA8 GP1BA DOP1B DNAH3 BRME1 LAMB3 PCDHA5 HUWE1 RNF123 GTF3C1 TBK1 PRKDC NUP188	4.59e-09	736	209	21	29676528
Pubmed	The RNA binding protein MEX3A promotes tumor progression of breast cancer by post-transcriptional regulation of IGFBP4.	URB2 AHDC1 TNRC18 SACS AP5Z1 SHOC1 NAV1 AHCTF1 HUWE1 MYOF MACF1 PRKDC SLC4A5	1.29e-07	332	209	13	37433992
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: II. The complete nucleotide sequences of 400 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	AVL9 TMEM94 URB2 SLC12A5 C2CD2L DENND4B NAV1 DOP1B FNIP2 FRAS1 HDAC5 ARFGEF3 DOCK7 MACF1	2.05e-07	407	209	14	12693553
Pubmed	The C2 domains of otoferlin, dysferlin, and myoferlin alter the packing of lipid bilayers.	DYSF OTOF MYOF	2.14e-07	3	209	3	23859474
Pubmed	Characterization of genes encoding known and novel human mast cell tryptases on chromosome 16p13.3.	TPSAB1 TPSD1 TPSB2	2.14e-07	3	209	3	9920877
Pubmed	FerA is a Membrane-Associating Four-Helix Bundle Domain in the Ferlin Family of Membrane-Fusion Proteins.	DYSF OTOF MYOF	2.14e-07	3	209	3	30026467
Pubmed	Human subjects are protected from mast cell tryptase deficiency despite frequent inheritance of loss-of-function mutations.	TPSAB1 TPSD1 TPSB2	2.14e-07	3	209	3	19748655
Pubmed	Expression of Fraser syndrome genes in normal and polycystic murine kidneys.	FREM2 FRAS1 FREM3	2.14e-07	3	209	3	21993971
Pubmed	Prediction of the coding sequences of unidentified human genes. XV. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro.	ESYT2 SULF2 NAV1 KCNH3 ARFGEF3 MYOF MACF1 GRIP2	2.17e-07	103	209	8	10574462
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: IV. The complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	HDAC9 RTEL1 SEMA4C CEP68 NEK1 TNRC18 SACS ADAMTS16 GRIN3A EXOC7 RNF169 SH3RF1 EPB41L5 MYOF MACF1	3.57e-07	493	209	15	15368895
Pubmed	Cullin 1 (CUL1) Promotes Primary Ciliogenesis through the Induction of Ubiquitin-Proteasome-Dependent Dvl2 Degradation.	RTEL1 CDH23 ADGRV1 HSPA8 FRAS1 MACF1 NUP188 CAPRIN1 HTT	3.84e-07	152	209	9	34299191
Pubmed	C5orf51 is a component of the MON1-CCZ1 complex and controls RAB7A localization and stability during mitophagy.	PEX1 RABL3 SEMA4C ITPR3 ESYT2 DOP1B FNIP2 SLC12A6 VEZT SCYL3 KIF16B ARFGEF3 NBAS LRCH4 AKAP11	4.72e-07	504	209	15	34432599
Pubmed	Identifications of novel host cell factors that interact with the receptor-binding domain of the SARS-CoV-2 spike protein.	PEX1 DGKA DOCK5 FREM2 TMEM62 SULF2 ANAPC2 EXOC7 SF3B2 PPP4R1 FRAS1 LAMB3 GTF3C1 TBK1 DOCK7 LRCH4 PCDHGC3	4.86e-07	650	209	17	38777146
Pubmed	Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.	URB2 ITPR3 PNPT1 MDN1 NOC4L UTP20 HSPA2 SF3B2 AHCTF1 HUWE1 TGM3 GTF3C1 DOCK7 MACF1 PRKDC NUP188 CAPRIN1	5.18e-07	653	209	17	22586326
Pubmed	Interactomes of Glycogen Synthase Kinase-3 Isoforms.	PPP1R13L ADD3 NEK1 ESYT2 EIF4ENIF1 ARFGEF3 DOCK7 MACF1 AKAP11 CAPRIN1	6.18e-07	209	209	10	36779422
Pubmed	Differential localization profile of Fras1/Frem proteins in epithelial basement membranes of newborn and adult mice.	FREM2 FRAS1 FREM3	8.52e-07	4	209	3	18563433
Pubmed	Segmental and restricted localization pattern of Fras1 in the developing meningeal basement membrane in mouse.	FREM2 FRAS1 FREM3	8.52e-07	4	209	3	24101214
Pubmed	Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.	EPHB6 HDAC9 DCHS2 ADD3 NELL2 OTOF SACS UBE3A SULF1 SCG2 HPS4 EXOC7 HSPA2 MNAT1 SF3B2 DOP1B PPP4R1 HUWE1 RNF123 SBNO1 MTM1 MACF1 PRKDC CAPRIN1	9.75e-07	1285	209	24	35914814
Pubmed	Spatiotemporal distribution of Fras1/Frem proteins during mouse embryonic development.	FREM2 FRAS1 FREM3	2.12e-06	5	209	3	17251066
Pubmed	Basement membrane localization of Frem3 is independent of the Fras1/Frem1/Frem2 protein complex within the sublamina densa.	FREM2 FRAS1 FREM3	2.12e-06	5	209	3	17596926
Pubmed	A direct functional link between the multi-PDZ domain protein GRIP1 and the Fraser syndrome protein Fras1.	FREM2 FRAS1 FREM3 GRIP2	3.63e-06	18	209	4	14730302
Pubmed	A High-Density Human Mitochondrial Proximity Interaction Network.	PEX1 RABL3 LACTB ITPR3 C2CD2L PNPT1 ESYT2 MDN1 ADSL EIF4ENIF1 ANGEL2 NAV1 NOC4L MTO1 VEZT AHCTF1 KIF16B ADCK2 HUWE1 ARFGEF3 GLMN NBAS AKAP11 NUP188 CAPRIN1	4.12e-06	1496	209	25	32877691
Pubmed	New developments in the genetics and activation of mast cell proteases.	TPSAB1 TPSD1 TPSB2	4.22e-06	6	209	3	12217407
Pubmed	Frem3, a member of the 12 CSPG repeats-containing extracellular matrix protein family, is a basement membrane protein with tissue distribution patterns distinct from those of Fras1, Frem2, and QBRICK/Frem1.	FREM2 FRAS1 FREM3	4.22e-06	6	209	3	17462874
Pubmed	LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling.	PEX1 URB2 RABL3 SEMA4C ITPR3 ESYT2 UBE3A ANAPC2 UTP20 EXOC7 HSPA2 VEZT AHCTF1 HUWE1 ARFGEF3 GLMN TBK1 PRKDC NUP188	4.76e-06	942	209	19	31073040
Pubmed	The matrisome: in silico definition and in vivo characterization by proteomics of normal and tumor extracellular matrices.	FREM2 HMCN2 SERPINF2 FRAS1 LAMA4 LAMB3 ITIH5 TGM3	8.31e-06	167	209	8	22159717
Pubmed	Proximity-dependent biotin identification (BioID) reveals a dynamic LSD1-CoREST interactome during embryonic stem cell differentiation.	BAP1 NEK1 EIF4ENIF1 NAV1 SLC39A7 KNL1 SFMBT1 HDAC5 HUWE1 GTF3C1 TBK1 DOCK7	9.74e-06	418	209	12	34709266
Pubmed	An antibody-based proximity labeling map reveals mechanisms of SARS-CoV-2 inhibition of antiviral immunity.	TMEM94 PPP1R13L AFAP1L1 C2CD2L EIF4ENIF1 NAV1 EXOC7 SF3B2 KNL1 RNF169 VEZT EPB41L5 HUWE1 GLMN NBAS LRCH4	1.05e-05	733	209	16	34672954
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	CDH26 RTEL1 ANKMY1 ADGRV1 ARHGEF16 AHDC1 DOCK5 KMT2C ESYT2 TNRC18 NAV1 NLRC5 SLC12A6 VEZT PCDHGB1 KSR2 SYT2 HUWE1 ARFGEF3 GTF3C1 TBK1 MACF1 SLC4A5 HTT	1.18e-05	1489	209	24	28611215
Pubmed	Prediction of the coding sequences of mouse homologues of FLJ genes: the complete nucleotide sequences of 110 mouse FLJ-homologous cDnas identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	DYSF GPAT2 ABCC10 DOCK8 RAB11FIP1 LRCH4	1.29e-05	85	209	6	15449545
Pubmed	Protein interaction network of the mammalian Hippo pathway reveals mechanisms of kinase-phosphatase interactions.	EIF4ENIF1 NAV1 CRTC3 SH3RF1 HDAC5 DOCK8 RAB11FIP1 GLMN TBK1 DOCK7 LRCH4 PRKDC	1.85e-05	446	209	12	24255178
Pubmed	Interaction with protocadherin-gamma regulates the cell surface expression of protocadherin-alpha.	PCDHGB1 PCDHGA9 PCDHA5 PCDHGC3	2.32e-05	28	209	4	15347688
Pubmed	The extracellular matrix gene Frem1 is essential for the normal adhesion of the embryonic epidermis.	FREM2 FRAS1 FREM3	2.49e-05	10	209	3	15345741
Pubmed	A forward genetics screen in mice identifies recessive deafness traits and reveals that pejvakin is essential for outer hair cell function.	CDH23 ADGRV1 OTOF	2.49e-05	10	209	3	17329413
Pubmed	FAM105A/OTULINL Is a Pseudodeubiquitinase of the OTU-Class that Localizes to the ER Membrane.	PEX1 RABL3 SEMA4C ITPR3 C2CD2L BTN3A3 ESYT2 DENND4B VEZT SCYL3 KIF16B NBAS	2.96e-05	468	209	12	31056421
Pubmed	Isolation and characterization of proteins associated with histone H3 tails in vivo.	HDAC9 KMT2C SF3B2 HDAC5	3.07e-05	30	209	4	17403666
Pubmed	LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy.	ITPR3 DOCK5 UTP20 NBAS MYOF DOCK7 PRKDC CAPRIN1	3.28e-05	202	209	8	33005030
Pubmed	Comprehensive interactome profiling of the human Hsp70 network highlights functional differentiation of J domains.	SPART RABL3 LACTB ADD3 ITPR3 PNPT1 ESYT2 MDN1 SACS NOC4L HSPA2 SF3B2 HSPA8 FRAS1 VEZT AHCTF1 KIF16B EPB41L5 RAB11FIP1 NBAS MACF1 AKAP11 CAPRIN1	3.46e-05	1487	209	23	33957083
Pubmed	Calcium-sensitive phospholipid binding properties of normal and mutant ferlin C2 domains.	DYSF MYOF	3.59e-05	2	209	2	11959863
Pubmed	Heparan sulfate 6-O-endosulfatases: discrete in vivo activities and functional co-operativity.	SULF2 SULF1	3.59e-05	2	209	2	16901266
Pubmed	Loss of dysferlin or myoferlin results in differential defects in excitation-contraction coupling in mouse skeletal muscle.	DYSF MYOF	3.59e-05	2	209	2	34354129
Pubmed	Ferlin Overview: From Membrane to Cancer Biology.	OTOF MYOF	3.59e-05	2	209	2	31443490
Pubmed	The structure of the human betaII-tryptase tetramer: fo(u)r better or worse.	TPSAB1 TPSB2	3.59e-05	2	209	2	10500112
Pubmed	The mouse mast cell-restricted tetramer-forming tryptases mouse mast cell protease 6 and mouse mast cell protease 7 are critical mediators in inflammatory arthritis.	TPSAB1 TPSD1	3.59e-05	2	209	2	18668540
Pubmed	Identification of two novel CAKUT-causing genes by massively parallel exon resequencing of candidate genes in patients with unilateral renal agenesis.	FREM2 FRAS1	3.59e-05	2	209	2	21900877
Pubmed	HSulf-1 and HSulf-2 are potent inhibitors of myeloma tumor growth in vivo.	SULF2 SULF1	3.59e-05	2	209	2	16192265
Pubmed	Epithelial Deletion of Sulf2 Exacerbates Bleomycin-Induced Lung Injury, Inflammation, and Mortality.	SULF2 SULF1	3.59e-05	2	209	2	28657777
Pubmed	Phosphorylation of activation function-1 regulates proteasome-dependent nuclear mobility and E6-associated protein ubiquitin ligase recruitment to the estrogen receptor beta.	ESR2 UBE3A	3.59e-05	2	209	2	17962381
Pubmed	SULF1/SULF2 splice variants differentially regulate pancreatic tumour growth progression.	SULF2 SULF1	3.59e-05	2	209	2	24726914
Pubmed	Apigenin manipulates the ubiquitin-proteasome system to rescue estrogen receptor-β from degradation and induce apoptosis in prostate cancer cells.	ESR2 UBE3A	3.59e-05	2	209	2	25408199
Pubmed	Differential involvement of the extracellular 6-O-endosulfatases Sulf1 and Sulf2 in brain development and neuronal and behavioural plasticity.	SULF2 SULF1	3.59e-05	2	209	2	20394677
Pubmed	Characterization of two highly polymorphic human tryptase loci and comparison with a newly discovered monkey tryptase ortholog.	TPSAB1 TPSB2	3.59e-05	2	209	2	10898108
Pubmed	SULFs in human neoplasia: implication as progression and prognosis factors.	SULF2 SULF1	3.59e-05	2	209	2	21599997
Pubmed	Caspr3-Deficient Mice Exhibit Low Motor Learning during the Early Phase of the Accelerated Rotarod Task.	CNTNAP3B CNTNAP3	3.59e-05	2	209	2	26807827
Pubmed	Fate of two mast cell tryptases in V3 mastocytosis and normal BALB/c mice undergoing passive systemic anaphylaxis: prolonged retention of exocytosed mMCP-6 in connective tissues, and rapid accumulation of enzymatically active mMCP-7 in the blood.	TPSAB1 TPSD1	3.59e-05	2	209	2	9064323
Pubmed	Impaired mitochondrial dynamics underlie axonal defects in hereditary spastic paraplegias.	AP5Z1 ZFYVE26	3.59e-05	2	209	2	29726929
Pubmed	Short SULF1/SULF2 splice variants predominate in mammary tumours with a potential to facilitate receptor tyrosine kinase-mediated cell signalling.	SULF2 SULF1	3.59e-05	2	209	2	27294358
Pubmed	Human beta-tryptase is a ring-like tetramer with active sites facing a central pore.	TPSAB1 TPSB2	3.59e-05	2	209	2	9521329
Pubmed	Extracellular sulfatases support cartilage homeostasis by regulating BMP and FGF signaling pathways.	SULF2 SULF1	3.59e-05	2	209	2	20479257
Pubmed	Molecular study of 33 families with Fraser syndrome new data and mutation review.	FREM2 FRAS1	3.59e-05	2	209	2	18671281
Pubmed	Delta tryptase is expressed in multiple human tissues, and a recombinant form has proteolytic activity.	TPSAB1 TPSD1	3.59e-05	2	209	2	12391231
Pubmed	Sulf1 and Sulf2 Differentially Modulate Heparan Sulfate Proteoglycan Sulfation during Postnatal Cerebellum Development: Evidence for Neuroprotective and Neurite Outgrowth Promoting Functions.	SULF2 SULF1	3.59e-05	2	209	2	26448642
Pubmed	Novel loss of function variants in FRAS1 AND FREM2 underlie renal agenesis in consanguineous families.	FREM2 FRAS1	3.59e-05	2	209	2	32643034
Pubmed	Diffusion magnetic resonance tractography-based evaluation of commissural fiber abnormalities in a heparan sulfate endosulfatase-deficient mouse brain.	SULF2 SULF1	3.59e-05	2	209	2	35131262
Pubmed	Human tryptases alpha and beta/II are functionally distinct due, in part, to a single amino acid difference in one of the surface loops that forms the substrate-binding cleft.	TPSAB1 TPSB2	3.59e-05	2	209	2	10391906
Pubmed	Genetic deficiency of human mast cell alpha-tryptase.	TPSAB1 TPSD1	3.59e-05	2	209	2	12100045
Pubmed	Loss-of-function mutations in MYO15A and OTOF cause non-syndromic hearing loss in two Yemeni families.	OTOF MYO15A	3.59e-05	2	209	2	37189200
Pubmed	Identification and molecular cloning of a novel mouse mucosal mast cell serine protease.	TPSAB1 TPSD1	3.59e-05	2	209	2	1688433
Pubmed	Expression of Heparan Sulfate Endosulfatases in the Adult Mouse Brain: Co-expression of Sulf1 and Dopamine D1/D2 Receptors.	SULF2 SULF1	3.59e-05	2	209	2	34489650
Pubmed	Lack of expression of the tryptase mouse mast cell protease 7 in mast cells of the C57BL/6J mouse.	TPSAB1 TPSD1	3.59e-05	2	209	2	8077672
Pubmed	N-myc downstream-regulated gene 2 promotes the protein stability of estrogen receptor beta via inhibition of ubiquitin-protein ligase E3A to suppress colorectal cancer.	ESR2 UBE3A	3.59e-05	2	209	2	33456993
Pubmed	Transcriptional regulation of mouse mast cell protease-7 by TGF-beta.	TPSAB1 TPSD1	3.59e-05	2	209	2	16730810
Pubmed	Sulfs are regulators of growth factor signaling for satellite cell differentiation and muscle regeneration.	SULF2 SULF1	3.59e-05	2	209	2	17920055
Pubmed	NLRC5 exerts anti-endometriosis effects through inhibiting ERβ-mediated inflammatory response.	ESR2 NLRC5	3.59e-05	2	209	2	39218863
Pubmed	Cloning and characterization of two extracellular heparin-degrading endosulfatases in mice and humans.	SULF2 SULF1	3.59e-05	2	209	2	12368295
Pubmed	A missense mutation in the conserved C2B domain of otoferlin causes deafness in a new mouse model of DFNB9.	CDH23 OTOF	3.59e-05	2	209	2	17967520
Pubmed	Overexpression of Sulf2 in idiopathic pulmonary fibrosis.	SULF2 SULF1	3.59e-05	2	209	2	23418199
Pubmed	The critical role of ASD-related gene CNTNAP3 in regulating synaptic development and social behavior in mice.	CNTNAP3B CNTNAP3	3.59e-05	2	209	2	31150793
Pubmed	BAP1 regulates IP3R3-mediated Ca2+ flux to mitochondria suppressing cell transformation.	BAP1 ITPR3	3.59e-05	2	209	2	28614305
Pubmed	Partial dysferlin reconstitution by adult murine mesoangioblasts is sufficient for full functional recovery in a murine model of dysferlinopathy.	DYSF PRKDC	3.59e-05	2	209	2	21364666
Pubmed	Regulation of fractone heparan sulfate composition in young and aged subventricular zone neurogenic niches.	SULF2 SULF1	3.59e-05	2	209	2	34324645
Pubmed	Sulf loss influences N-, 2-O-, and 6-O-sulfation of multiple heparan sulfate proteoglycans and modulates fibroblast growth factor signaling.	SULF2 SULF1	3.59e-05	2	209	2	18687675
Pubmed	Loss of endothelial sulfatase-1 after experimental sepsis attenuates subsequent pulmonary inflammatory responses.	SULF2 SULF1	3.59e-05	2	209	2	31461325
Pubmed	Characterization of a tryptase mRNA expressed in the human basophil cell line KU812.	TPSAB1 TPSB2	3.59e-05	2	209	2	8434231
Pubmed	Structural Basis for the Distinct Membrane Binding Activity of the Homologous C2A Domains of Myoferlin and Dysferlin.	DYSF MYOF	3.59e-05	2	209	2	31004665
Pubmed	Suppressing aberrant GluN3A expression rescues synaptic and behavioral impairments in Huntington's disease models.	GRIN3A HTT	3.59e-05	2	209	2	23852340
Pubmed	Functional consequences of the subdomain organization of the sulfs.	SULF2 SULF1	3.59e-05	2	209	2	19520866
Pubmed	In silico discovery and experimental validation of new protein-protein interactions.	DYSF HTT	3.59e-05	2	209	2	21280221
Pubmed	The SULFs, extracellular sulfatases for heparan sulfate, promote the migration of corneal epithelial cells during wound repair.	SULF2 SULF1	3.59e-05	2	209	2	23950901
Pubmed	Increase in TPSB2 and TPSD1 Expression in Synovium of Hip Osteoarthritis Patients Who Are Overweight.	TPSD1 TPSB2	3.59e-05	2	209	2	37511292
Pubmed	Alternate mRNA splicing in multiple human tryptase genes is predicted to regulate tetramer formation.	TPSAB1 TPSD1	3.59e-05	2	209	2	18854315
Pubmed	Cloning and characterization of a second complementary DNA for human tryptase.	TPSAB1 TPSB2	3.59e-05	2	209	2	2203827
Pubmed	Endosulfatases SULF1 and SULF2 limit Chlamydia muridarum infection.	SULF2 SULF1	3.59e-05	2	209	2	23480519
Pubmed	Expression of novel extracellular sulfatases Sulf-1 and Sulf-2 in normal and osteoarthritic articular cartilage.	SULF2 SULF1	3.59e-05	2	209	2	18507859
Pubmed	Heparan sulfate 6-O-endosulfatases, Sulf1 and Sulf2, regulate glomerular integrity by modulating growth factor signaling.	SULF2 SULF1	3.59e-05	2	209	2	26764203
Pubmed	SULF1/SULF2 reactivation during liver damage and tumour growth.	SULF2 SULF1	3.59e-05	2	209	2	27013228
Pubmed	While dysferlin and myoferlin are coexpressed in the human placenta, only dysferlin expression is responsive to trophoblast fusion in model systems.	DYSF MYOF	3.59e-05	2	209	2	19228595
Pubmed	Essential role for mast cell tryptase in acute experimental colitis.	TPSAB1 TPSD1	3.59e-05	2	209	2	21173247
Interaction	PFN1 interactions	ESR2 BAP1 SEMA4C NEK1 ESYT2 NAV1 SF3B2 HSPA8 DOP1B HDAC5 DOCK8 TFE3 NBAS RNF123 DOCK7 MACF1 HTT MTSS2	3.24e-06	509	199	18	int:PFN1
Interaction	EEF1AKMT3 interactions	RTEL1 PEX1 DGKA DOCK5 MDN1 UBE3A NAV1 GPAT2 HSPA2 HSPA8 HUWE1 RNF123 GTF3C1 TBK1 DOCK7	3.57e-06	364	199	15	int:EEF1AKMT3
Interaction	PCDHGB2 interactions	PPP1R13L C2CD2L VEZT PCDHGB1 PCDHGA9 PCDHGC3	4.44e-06	44	199	6	int:PCDHGB2
Interaction	D2HGDH interactions	RTEL1 PEX1 PPP1R13L GPAT2 MNAT1 HSPA8 RNF123 TBK1 DOCK7	1.50e-05	146	199	9	int:D2HGDH
Interaction	CDH26 interactions	CDH26 MNAT1 HTT	1.86e-05	6	199	3	int:CDH26
Interaction	TOP3B interactions	RTEL1 TMEM94 DGKQ DYSF AHDC1 BAP1 ITPR3 C2CD2L KMT2C TNRC18 MDN1 EIF4ENIF1 NAV1 NLRC5 ABCC10 ENGASE FRAS1 SH3RF1 RRM2B L1CAM KSR2 LAMB3 HUWE1 TFE3 KCNH3 MYOF ZNF500 ZFYVE26 PRKDC NUP188 CAPRIN1 HTT	1.94e-05	1470	199	32	int:TOP3B
Interaction	NPTN interactions	MDN1 AP5Z1 ANAPC2 NOC4L UTP20 EXOC7 DOP1B SYT2 HUWE1 ARFGEF3 ZFYVE26 HTT	2.19e-05	278	199	12	int:NPTN
Interaction	SULF2 interactions	ESR2 CDH23 TNRC18 SULF2 SULF1 EPB41L5 AKAP11 IL5RA	2.41e-05	119	199	8	int:SULF2
Interaction	MEX3A interactions	URB2 AHDC1 TNRC18 EIF4ENIF1 SACS AP5Z1 SHOC1 NAV1 AHCTF1 HUWE1 MYOF MACF1 PRKDC SLC4A5	2.98e-05	384	199	14	int:MEX3A
Interaction	BAG2 interactions	PEX1 PPP1R13L BAP1 DOCK5 EIF4ENIF1 AP5Z1 MTO1 HSPA2 HSPA8 KNL1 SLC12A6 HDAC5 RRM2B KIF16B LAMB3 HUWE1 DOCK7 HTT	4.77e-05	622	199	18	int:BAG2
Interaction	GPR182 interactions	URB2 DOCK5 ESYT2 MDN1 AP5Z1 NAV1 UTP20 EXOC7 GPAT2 DOP1B AHCTF1 ADCK2 ARFGEF3 PRKDC HTT	4.91e-05	455	199	15	int:GPR182
Interaction	PCDHGB3 interactions	PCDHGB1 RNF123 PCDHGC3	5.12e-05	8	199	3	int:PCDHGB3
Interaction	LTA4H interactions	BAP1 TMEM62 ADSL HSPA8 HDAC5 RNF123	6.14e-05	69	199	6	int:LTA4H
Interaction	FBXO2 interactions	CNTNAP3B CNTNAP3 ADGRV1 SEMA4C NELL2 SULF2 SULF1 ANAPC2 FRAS1 VASN L1CAM LAMA4 LAMB3 HTT	6.21e-05	411	199	14	int:FBXO2
Interaction	RNF123 interactions	DGKA DOCK5 KMT2C FREM2 MDN1 DENND4B UTP20 OR7A10 HSPA8 GP1BA DOP1B DNAH3 BRME1 LAMB3 PCDHA5 HUWE1 RNF123 GTF3C1 TBK1 PRKDC NUP188	6.97e-05	824	199	21	int:RNF123
Interaction	CDRT15P3 interactions	RTEL1 PEX1 HSPA2 HSPA8	8.40e-05	24	199	4	int:CDRT15P3
GeneFamily	Ferlin family	DYSF OTOF MYOF	8.74e-06	6	139	3	828
GeneFamily	Olfactory receptors, family 12	OR12D2 OR12D1	1.75e-04	3	139	2	160
GeneFamily	Serpin peptidase inhibitors	SERPINB9 SERPINB10 SERPINF2 SERPINB2	1.81e-04	37	139	4	739
GeneFamily	Histone deacetylases, class IIA	HDAC9 HDAC5	3.49e-04	4	139	2	992
GeneFamily	Clustered protocadherins	PCDHGB1 PCDHGA9 PCDHA5 PCDHGC3	1.49e-03	64	139	4	20
GeneFamily	EF-hand domain containing\|Diacylglycerol kinases	DGKA DGKQ	2.54e-03	10	139	2	1178
GeneFamily	Armadillo repeat containing\|Protein phosphatase 1 regulatory subunits	ITPR3 SACS KNL1 ARFGEF3 PPP1R18 AKAP11	2.77e-03	181	139	6	694
ToppCell	Control-Control-Lymphocyte-T/NK-CD4+_T_activated\|Control / Disease, condition lineage and cell class	CNTNAP3 DGKA SIRPG BTN3A3 NLRC5 THEMIS PLCD4 ADCK2 MACF1 AKAP11 LTB	2.71e-09	198	209	11	ee71543559836fd59adc0da877b2ca538cba60cb
ToppCell	LPS-antiTNF-Hematopoietic_Meg-Ery-Mes-Epi-like-Erythroid\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	HDAC9 ASIC2 FHAD1 SERPINB10 ATP13A4 DNAH3 RRM2B FICD ZNF500	1.82e-08	137	209	9	8e2fa2ef8becace96a68bb85c002329110902fbb
ToppCell	CV-Moderate-7\|Moderate / Virus stimulation, Condition and Cluster	AVL9 DENND4B DOP1B DOCK8 AHCTF1 HUWE1 NBAS MTM1 MACF1 PRKDC	1.88e-08	185	209	10	a6c9203ce6c2892a4a369c9bcfb85720f01cbb3f
ToppCell	Control-Epithelial_cells\|Control / group, cell type (main and fine annotations)	ADGRV1 DOCK5 FREM2 PPP4R1 ATP13A4 SH3RF1 EPB41L5 RAB11FIP1 ARFGEF3 LRRC36	2.19e-08	188	209	10	707ebf76cc6fb600b2f07793cf4ea9482c0de79d
ToppCell	Parenchymal-10x5prime-Immune_Myeloid-Dendritic_cell-DC_1\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	HDAC9 OXCT2 SULF2 SERPINB9 CLCN1 SERPINF2 SLC30A10 UTF1 KIF16B LTB	3.75e-08	199	209	10	26ea06960e8ea061a71756750b84489609f78162
ToppCell	Hippocampus-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Cbln1-Excitatory_Neuron.Slc17a7.Cbln1-Trps1_(Medial_entorrhinal_cortex,_Cbln1+/Trps1+)-\|Hippocampus / BrainAtlas - Mouse McCarroll V32	ESR2 CDH23 THEMIS ITPRID1 FREM3 SERPINB2	1.41e-07	51	209	6	9656b37262f228753203ca49aab93e86066b69a5
ToppCell	Hippocampus-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Cbln1-Excitatory_Neuron.Slc17a7.Cbln1-Trps1_(Medial_entorrhinal_cortex,_Cbln1+/Trps1+)\|Hippocampus / BrainAtlas - Mouse McCarroll V32	ESR2 CDH23 THEMIS ITPRID1 FREM3 SERPINB2	1.41e-07	51	209	6	10cfed29c2fa495d4527e1e4d8edf21edaf1d0fa
ToppCell	10x5'-lymph-node_spleen-Myeloid_Dendritic-DC1\|lymph-node_spleen / Manually curated celltypes from each tissue	HDAC9 ASIC2 DYSF SULF2 CLCN1 NAV1 SERPINF2 FNIP2 TYMP	2.19e-07	183	209	9	c9e3d91f4c3395a73295b92e25608e0effb5d241
ToppCell	CV-Moderate-7\|CV / Virus stimulation, Condition and Cluster	AVL9 DOP1B DOCK8 AHCTF1 HUWE1 NBAS MTM1 MACF1 PRKDC	2.52e-07	186	209	9	8571956890fc9894d766ba294a28e376b4aba428
ToppCell	COVID-19-COVID-19_Mild-Lymphocyte-T/NK-CD4+_T_activated\|COVID-19_Mild / Disease, condition lineage and cell class	DGKA ADD3 SIRPG PNPT1 MDN1 GIMAP6 HSPA8 THEMIS LTB	4.63e-07	200	209	9	d9e8a0d047d4403fb7265fde7448e23a7780785c
ToppCell	Control\|World / group, cell type (main and fine annotations)	ADGRV1 FREM2 ATP13A4 SH3RF1 EPB41L5 RAB11FIP1 ARFGEF3 LRRC36	1.33e-06	168	209	8	a3511faf2cd2c2b9c8363c8b99da3f3609c43ed6
ToppCell	wk_08-11-Epithelial-PNS-FGFBP2+_Neural_progenitor\|wk_08-11 / Celltypes from embryonic and fetal-stage human lung	HDAC9 NELL2 SCG2 NLRC5 L1CAM PLCD4 TPSD1 GRIP2	1.97e-06	177	209	8	15a5c96ea840376e54933ebe7a8334a11d9ce411
ToppCell	PND28-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1-AT1_mature\|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	ARHGEF16 SERPINB9 ATP13A4 EPB41L5 LAMB3 RAB11FIP1 PRKAG3 SLC4A5	2.06e-06	178	209	8	a3af5d9c55858e36be0498081029ecb0acaeb3d3
ToppCell	PND28-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1\|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	ARHGEF16 SERPINB9 ATP13A4 EPB41L5 LAMB3 RAB11FIP1 PRKAG3 SLC4A5	2.06e-06	178	209	8	b3b88989bd602cfb55bb5c47731deb99288a8952
ToppCell	Posterior_cortex-Neuronal-Excitatory-eN1(Slc17a7)-eN1_1-Calb1-Excitatory_Neuron.Slc17a7-Slc17a6.Calb1-Rorb-Il1rapl2_(Layer_5b)\|Posterior_cortex / BrainAtlas - Mouse McCarroll V32	ESR2 ANKMY1 FRAS1 LAMB3 TGM3 MYO15A	2.11e-06	80	209	6	402aba070f0728ebda9db7a8fa85441533755ff4
ToppCell	BAL-Severe-Myeloid-cDC-cDC-cDC_11\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	HDAC9 SULF2 SERPINB9 CLCN1 NAV1 SERPINF2 KIF16B RAB11FIP1	2.63e-06	184	209	8	667846c422cfa27e949a24844a305df859cb6760
ToppCell	BAL-Severe-Myeloid-cDC-cDC-cDC_11\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	HDAC9 SULF2 SERPINB9 CLCN1 NAV1 SERPINF2 KIF16B RAB11FIP1	2.63e-06	184	209	8	a6f8b42982ec0cf44b950a2cd9715d068eec4ecb
ToppCell	368C-Myeloid-Dendritic-cDC_proliferating_1\|Dendritic / Donor, Lineage, Cell class and subclass (all cells)	CDH23 MDN1 GPAT2 KNL1 ATP13A4 SH3RF1 UBE2C KLHL31	2.85e-06	186	209	8	5cadab3271fce9ab6da3d7ba9827b8a221cac166
ToppCell	normal_Lung-Myeloid_cells-CD141+_DCs\|normal_Lung / Location, Cell class and cell subclass	HDAC9 SULF2 SERPINB9 CLCN1 NAV1 SERPINF2 KIF16B RAB11FIP1	2.85e-06	186	209	8	a6698a2f4edd81b67e06531ede0e207dd0309205
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	HDAC9 ASIC2 ITPR3 ESYT2 PPP4R1 LAMA4 LAMB3 MYOF	2.97e-06	187	209	8	42a1267bfc27b4460b8409ada580a87c4385841c
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	HDAC9 ASIC2 ITPR3 ESYT2 PPP4R1 LAMA4 LAMB3 MYOF	2.97e-06	187	209	8	64afdea159f5e67a1e5cea35ce898aae6e80aea5
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	HDAC9 ASIC2 ITPR3 ESYT2 PPP4R1 LAMA4 LAMB3 MYOF	2.97e-06	187	209	8	87b3d0478693d4c54ff06b74e5903036b9c1ee6a
ToppCell	COVID-19-Myeloid-DC1\|COVID-19 / Condition, Lineage and Cell class	HDAC9 SULF2 SERPINB9 CLCN1 NAV1 SERPINF2 KIF16B ABCA6	3.47e-06	191	209	8	9e44357cdeca46d2b26124bb063c8422ef930083
ToppCell	COPD-Myeloid-cDC1\|COPD / Disease state, Lineage and Cell class	HDAC9 SULF2 SERPINB9 SERPINF2 FNIP2 KIF16B RAB11FIP1 MTSS2	3.61e-06	192	209	8	bd3d00b094d92463b06023361a71240851a542b8
ToppCell	Fetal_29-31_weeks-Epithelial\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	ADGRV1 ITPR3 FREM2 ATP13A4 SH3RF1 EPB41L5 RAB11FIP1 ARFGEF3	3.75e-06	193	209	8	a0ca3231992f14abcf1a6129573bace320e89d2a
ToppCell	3'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_T/NK-CD8-positive,_alpha-beta_T_cell-CD8_T_cells-CD8_T_cells_L.1.1.2.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	TPSAB1 SIRPG GIMAP6 HSPA8 THEMIS PPP1R18 LTB TPSB2	3.89e-06	194	209	8	9116451614431e3cf9bd7d4d626bf4bd23420e36
ToppCell	BAL-Severe-cDC_11\|Severe / Compartment, Disease Groups and Clusters	HDAC9 DYSF SERPINB9 CLCN1 SERPINF2 KIF16B RAB11FIP1 LTB	4.04e-06	195	209	8	2d31a1c2878c86a49a278b6c7decafabf26c3a5c
ToppCell	COVID_non-vent-Lymphocytic-T_cell\|COVID_non-vent / Disease condition, Lineage, Cell class and subclass	DGKA KMT2E ADD3 SIRPG NELL2 THEMIS MACF1 LTB	4.04e-06	195	209	8	4bdedd924564a260841a9153604026b57487c83d
ToppCell	3'_v3-Lung-Myeloid_Monocytic-Classical_monocytes\|Lung / Manually curated celltypes from each tissue	PLBD1 PADI4 ADGRE2 DYSF SULF2 SERPINB9 TYMP SERPINB2	4.70e-06	199	209	8	bfd0d171ea6bb7abd5cdfeac22608cc190aaa2be
ToppCell	Transverse-Dendritic_cell-cDC1\|Transverse / Region, Cell class and subclass	PLBD1 DYSF SULF2 CLCN1 NAV1 SERPINF2 FNIP2 KIF16B	4.70e-06	199	209	8	b68419939d206417158a703f60a374bf8ec5d5a1
ToppCell	Transverse-(5)_Dendritic_cell-(51)_cDC1\|Transverse / shred on region, Cell_type, and subtype	PLBD1 DYSF SULF2 CLCN1 NAV1 SERPINF2 FNIP2 KIF16B	4.70e-06	199	209	8	52dd1c4cd372f8ee515307a9200e357bb2145888
ToppCell	Sigmoid-(5)_Dendritic_cell-(51)_cDC1\|Sigmoid / shred on region, Cell_type, and subtype	PLBD1 DYSF SULF2 NAV1 SERPINF2 FNIP2 ISYNA1 SH3RF1	4.87e-06	200	209	8	4ce0a2238c90622e41fd86ac4b7d82adf4af2c3b
ToppCell	Sigmoid-Dendritic_cell-cDC1\|Sigmoid / Region, Cell class and subclass	PLBD1 DYSF SULF2 NAV1 SERPINF2 FNIP2 ISYNA1 SH3RF1	4.87e-06	200	209	8	3523ec986e8c9e176e08836c974b1de8b56d8b16
ToppCell	(51)_cDC1\|World / shred on Cell_type and subtype	PLBD1 DYSF SULF2 CLCN1 NAV1 SERPINF2 FNIP2 KIF16B	5.64e-06	204	209	8	a8cf4180c406674b7541917d1fc6127686ba5f8a
ToppCell	facs-Lung-18m-Hematologic-myeloid-non-classical_monocyte-nonclassical_monocyte_l4\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	PLBD1 DOCK5 SERPINB10 DENND4B DOCK8 L1CAM TGM3	9.94e-06	158	209	7	121d63b8e2e37107467b170e5b2c798a7dbf6325
ToppCell	facs-Lung-18m-Hematologic-myeloid-non-classical_monocyte\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	PLBD1 DOCK5 SERPINB10 DENND4B DOCK8 L1CAM TGM3	1.08e-05	160	209	7	bc4a93dc5f37829799c37877e751ff3bc122e4ab
ToppCell	10x5'-GI_large-bowel-Lymphocytic_T_CD4-Tfh\|GI_large-bowel / Manually curated celltypes from each tissue	EPHB6 DGKA ADGRV1 KMT2E AHDC1 TNRC18 KSR2	1.22e-05	163	209	7	4104d3b9748b39cb0744c9be76db21bdda566a0d
ToppCell	facs-Lung-3m-Hematologic-myeloid-non-classical_monocyte-nonclassical_monocyte_l4\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	PLBD1 CDH23 DOCK5 SERPINB10 DOCK8 L1CAM TGM3	1.27e-05	164	209	7	11dfd84f5fb90de330858e1e852848832734e004
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Immune-Myeloid-Granulocytic-Mast_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	TPSAB1 ADGRE2 NAV1 TPSD1 ADAMTS14 IL5RA TPSB2	1.27e-05	164	209	7	2c48c6e4eeee845f0563982d0bfa2a176ca5ef61
ToppCell	facs-Lung-nan-3m-Epithelial-type_I_pneumocyte\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ATP13A4 EPB41L5 LAMB3 RAB11FIP1 PRKAG3 ARFGEF3 PRKDC	1.37e-05	166	209	7	11b0ae82b3068ef91715dbdd49fe8e9791b4a480
ToppCell	facs-Lung-nan-3m-Epithelial-Alveolar_Epithelial_Type_1\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ATP13A4 EPB41L5 LAMB3 RAB11FIP1 PRKAG3 ARFGEF3 PRKDC	1.37e-05	166	209	7	fcc1aec31ebd39432d4cb284dc8fadf34e3c566a
ToppCell	3'-GW_trimst-2-SmallIntestine-Hematopoietic-Myeloid-CLC+_Mast_cell\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	TPSAB1 PADI4 ADGRE2 DOCK8 TPSD1 IL5RA TPSB2	1.79e-05	173	209	7	b9dc42d629d13e63aada5ae49ba0cbb0952c5fe9
ToppCell	BAL-Control-Myeloid-cDC-cDC-cDC_11\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	PADI4 SULF2 SERPINB9 NAV1 SERPINF2 UTF1 LTB	1.86e-05	174	209	7	c8cec89369cf3896c5626e447051e76a142cb6df
ToppCell	droplet-Lung-18m-Epithelial-airway_epithelial-club_cell\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	PPP1R13L FHAD1 RUNDC3A LAMB3 IFTAP SLC4A5 LRRC36	1.86e-05	174	209	7	46838b4bb9b4d8ce5e1c608a700e7f393bc52658
ToppCell	droplet-Lung-18m-Epithelial-airway_epithelial-club_cell-club_cell\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	PPP1R13L FHAD1 RUNDC3A LAMB3 IFTAP SLC4A5 LRRC36	1.86e-05	174	209	7	103594eeb600eb5bc9cbf09a65b286b3a3a18cdc
ToppCell	BAL-Control-Myeloid-cDC-cDC-cDC_11\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	PADI4 SULF2 SERPINB9 NAV1 SERPINF2 UTF1 LTB	1.86e-05	174	209	7	991f7eab69ea3ee1045a4e44ce60a96db13df6d1
ToppCell	Hippocampus-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Cbln1\|Hippocampus / BrainAtlas - Mouse McCarroll V32	ESR2 CDH23 THEMIS ITPRID1 SERPINB2	1.95e-05	70	209	5	8d6bdf2e773e894a0db39fdff1fafc2474e03fcf
ToppCell	3'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating-Lymphatic_EC_differentiating_L.2.5.1.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CNTNAP3B ADD3 AFAP1L1 DOCK5 CEP68 LAMA4 MACF1	2.15e-05	178	209	7	ad3de3e03a401dac64431a541899445262246347
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	ESR2 ADGRV1 FNIP2 ATP13A4 SH3RF1 EPB41L5 ARFGEF3	2.15e-05	178	209	7	f5ed4a6e3eb8056b1be1fb311021710c95bdf888
ToppCell	TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Mucinous_Colon_Adenocarcinoma-10\|TCGA-Colorectal / Sample_Type by Project: Shred V9	ADGRE2 DYSF AFAP1L1 ADAMTS16 DOCK8 PCDHGA9 LAMA4	2.23e-05	179	209	7	cc079ba015326dccde955c5eafa3e4a2e40de192
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c06-NR4A2\|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)	DGKA SIRPG NELL2 GIMAP6 HSPA8 THEMIS LTB	2.31e-05	180	209	7	f3d35b2ea78afef37a84232adf5e6e26712b618d
ToppCell	3'-GW_trimst-1-LargeIntestine-Hematopoietic-Myeloid-CLC+_Mast_cell\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	TPSAB1 PADI4 DOCK8 TPSD1 SERPINB2 IL5RA TPSB2	2.31e-05	180	209	7	1c5515f29ead129bee3b4ca27799796956811a39
ToppCell	3'-Pediatric_IBD-SmallIntestine-Hematopoietic-Myeloid-cDC1\|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract	SERPINB9 CLCN1 NAV1 SERPINF2 FNIP2 KIF16B TYMP	2.39e-05	181	209	7	84ca8c9c036478a6d3a2071919d09065455d417c
ToppCell	PND14-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1-AT1_mature\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	ATP13A4 FRAS1 EPB41L5 LAMB3 RAB11FIP1 TRIM3 PRKAG3	2.48e-05	182	209	7	573771130247e869e4e58f22d4a1cb31989635cf
ToppCell	PND14-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	ATP13A4 FRAS1 EPB41L5 LAMB3 RAB11FIP1 TRIM3 PRKAG3	2.48e-05	182	209	7	6cfaa2b3b3974c13b01c943f4adb70768dcc35e4
ToppCell	367C-Myeloid-Dendritic-cDC1\|367C / Donor, Lineage, Cell class and subclass (all cells)	HDAC9 PADI4 SERPINB9 SERPINF2 KIF16B RAB11FIP1 LTB	2.48e-05	182	209	7	6f5228ac47f9ab46d165740cf2655b5ba217acbe
ToppCell	5'-GW_trimst-2-LargeIntestine-Endothelial-lymphatic_endothelial\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CNTNAP3 DYSF AFAP1L1 DOCK5 CEP68 SULF2 SERPINB9	2.57e-05	183	209	7	764ea07621f77fbd13a877aed5806ae2b3dfb43e
ToppCell	COPD-Epithelial-ATII\|World / Disease state, Lineage and Cell class	ADGRV1 FREM2 ATP13A4 SH3RF1 ARFGEF3 CSF3 LRRC36	2.57e-05	183	209	7	8e9aab4eeec2e282c2cab9bfca6dbf40d660c7b9
ToppCell	3'_v3-Lung-Myeloid_Dendritic-DC1\|Lung / Manually curated celltypes from each tissue	HDAC9 SULF2 SERPINB9 SERPINF2 FNIP2 ABCA6 LTB	2.57e-05	183	209	7	e4cbd39575b5a4612d9934532e3bad63286f8aa5
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ADGRV1 FREM2 ADAMTS16 ATP13A4 FRAS1 ARFGEF3 MYO15A	2.66e-05	184	209	7	2cbed6462fea2622871bb7e49b0df3d984239281
ToppCell	BAL-Severe-Myeloid-cDC-cDC-cDC_3\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	HDAC9 NAV1 SERPINF2 UTF1 RAB11FIP1 ABCA6 LTB	2.66e-05	184	209	7	1c56378b3888c46258d446b47de4d6282fe74b0d
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ADGRV1 FREM2 ADAMTS16 ATP13A4 FRAS1 ARFGEF3 MYO15A	2.66e-05	184	209	7	2b19a8c5f823e00812908b23e66bb4e563278aff
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ADGRV1 FREM2 ADAMTS16 ATP13A4 FRAS1 ARFGEF3 MYO15A	2.66e-05	184	209	7	ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCell	BAL-Severe-Myeloid-cDC-cDC-cDC_3\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	HDAC9 NAV1 SERPINF2 UTF1 RAB11FIP1 ABCA6 LTB	2.66e-05	184	209	7	a45980306c4e697a2703bed72a7b48fb23d942f4
ToppCell	PCW_13-14-Endothelial-Endothelial_mature-lymphatic-endo_lymphatic_(7)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	CNTNAP3B CNTNAP3 DYSF AFAP1L1 SULF2 GIMAP6 DOCK8	2.75e-05	185	209	7	3be9e05b929ac4d956b1d53284072f668a6c1959
ToppCell	PCW_13-14-Endothelial-Endothelial_mature-lymphatic\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	CNTNAP3B CNTNAP3 DYSF AFAP1L1 SULF2 GIMAP6 DOCK8	2.75e-05	185	209	7	c3dd64a726cb8a1fe048683c266b7532a714a52e
ToppCell	PCW_07-8.5-Endothelial-Endothelial_mature-lymphatic\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	CNTNAP3B CNTNAP3 DYSF AFAP1L1 GIMAP6 DOCK8 LTB	2.85e-05	186	209	7	5d94e6dd2c92e0c46badeb1e6eb54b69af855a66
ToppCell	LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT1\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	PPP1R13L ATP13A4 FRAS1 EPB41L5 LAMB3 RAB11FIP1 MYOF	2.85e-05	186	209	7	3aebe163799109ffc67e4e10ee47c2dd0886a92c
ToppCell	10x5'-bone_marrow-Hematopoietic_progenitors-Cycling_pre-Myeloid-2\|bone_marrow / Manually curated celltypes from each tissue	PLBD1 PADI4 DYSF KNL1 UBE2C TYMP SERPINB2	2.85e-05	186	209	7	e82d5e7a976b9cfa2b4640c7a7cd1cfea19c4806
ToppCell	3'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CNTNAP3B ADD3 AFAP1L1 DOCK5 CEP68 LAMA4 MACF1	2.85e-05	186	209	7	20340a5b5cc7f07386498a4ef937d6fbc9e347c4
ToppCell	PCW_07-8.5-Endothelial-Endothelial_mature-lymphatic-endo_lymphatic_(7)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	CNTNAP3B CNTNAP3 DYSF AFAP1L1 GIMAP6 DOCK8 LTB	2.85e-05	186	209	7	1da52e13096dfe4eb08bd0e7461cb3809b3b3deb
ToppCell	367C-Myeloid-Dendritic-cDC1\|Myeloid / Donor, Lineage, Cell class and subclass (all cells)	HDAC9 SULF2 SERPINF2 KIF16B RAB11FIP1 PDP1 LTB	2.95e-05	187	209	7	3748203b62abf51b74dfcfc4f18b3ba831b63a96
ToppCell	3'_v3-lymph-node_spleen-Hematopoietic_progenitors-Cycling_pre-Myeloid-2\|lymph-node_spleen / Manually curated celltypes from each tissue	PADI4 NOC4L UTF1 TYMP SERPINB2 ZFYVE26 CAPRIN1	2.95e-05	187	209	7	3c10b8501226c69d71bcd99dc1c064a3c2154f87
ToppCell	systemic_lupus_erythematosus-flare-Hematopoietic\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	TPSAB1 DGKA ADD3 SIRPG SLC1A6 TPSD1 LTB	3.05e-05	188	209	7	88b808561ebde997ac8a8bbd1d9bbda49bbb6646
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	DOCK5 ATP13A4 SH3RF1 EPB41L5 LAMB3 RAB11FIP1 MYOF	3.05e-05	188	209	7	eea652bab161f19148a883e7e3fe2523b36b3cea
ToppCell	IPF-Myeloid-cDC1\|Myeloid / Disease state, Lineage and Cell class	HDAC9 SULF2 SERPINB9 NLRC5 SERPINF2 KIF16B LTB	3.05e-05	188	209	7	47bb6caf84f70a1cda7d09803afdfd5182772e66
ToppCell	Children_(3_yrs)-Endothelial-endothelial_cell_of_lymph_vessel\|Children_(3_yrs) / Lineage, Cell type, age group and donor	CNTNAP3B CNTNAP3 DYSF AFAP1L1 DOCK5 SULF2 LAMA4	3.05e-05	188	209	7	c2805232618a7b6f844d34e37ad458a9923dbfe1
ToppCell	IPF-Myeloid-cDC1\|IPF / Disease state, Lineage and Cell class	HDAC9 SULF2 SERPINB9 NLRC5 SERPINF2 KIF16B LTB	3.05e-05	188	209	7	2331a2bae1383820d598e93aa86c75b101069bac
ToppCell	Children_(3_yrs)-Endothelial-endothelial_cell_of_lymph_vessel-D046\|Children_(3_yrs) / Lineage, Cell type, age group and donor	CNTNAP3B CNTNAP3 DYSF AFAP1L1 DOCK5 SULF2 LAMA4	3.05e-05	188	209	7	2db80767903703e7e0a1a37c598f7877a909ee94
ToppCell	10x5'v1-week_12-13-Lymphocytic_T-T_NK-CD4_T_cell\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	DGKA ADD3 SIRPG NELL2 GIMAP6 THEMIS LTB	3.16e-05	189	209	7	0f0a1212e525a7385a27d625524fa7beffa90f44
ToppCell	PCW_07-8.5-Epithelial-Epithelial_airway-epi_proximal_progenitor1_(6)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	ADGRV1 FREM2 ATP13A4 FRAS1 KSR2 LAMB3 ARFGEF3	3.16e-05	189	209	7	7659c7bbd58ee959a159294fb8d17317bbcc5681
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	CNTNAP3B CNTNAP3 DYSF AFAP1L1 HMCN2 NAV1 ITIH5	3.16e-05	189	209	7	6463890d8dbee4bc198f91628a5f784970de786a
ToppCell	PCW_05-06-Epithelial-Epithelial_proliferating-epi_proliferating2_(13)\|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung	ADGRV1 ARHGEF16 FREM2 LAMB3 ITPRID1 ARFGEF3 LRRC36	3.16e-05	189	209	7	c8b8f860aaf6c73863cd79941db6b469c830ef06
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	CDH23 ABCA10 HMCN2 SULF1 GRIN3A LAMA4 ABCA6	3.27e-05	190	209	7	efb757f11c2809e66ddb48a5c84f5433f111cb7c
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Lymphocytic_T/NK-T_Cell-\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	DGKA SIRPG NELL2 NLRC5 THEMIS DOCK8 LTB	3.27e-05	190	209	7	5b4b3eed7aa798bb7e3c5e968c8dc4144e377a5f
ToppCell	COPD-Myeloid-ncMonocyte\|World / Disease state, Lineage and Cell class	PADI4 ADGRE2 ADD3 DOCK5 SULF2 SERPINB9 AHCTF1	3.27e-05	190	209	7	aece860b5609ad5a8fc920d685f0d0ec71bf9018
ToppCell	COPD-Myeloid-ncMonocyte\|Myeloid / Disease state, Lineage and Cell class	PADI4 ADGRE2 ADD3 DOCK5 SULF2 SERPINB9 AHCTF1	3.27e-05	190	209	7	ed978cd5d9da87b49878a330e362762c487f849f
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Lymphocytic_T/NK-T_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	DGKA SIRPG NELL2 NLRC5 THEMIS DOCK8 LTB	3.27e-05	190	209	7	07ea0578ca0561077557203ae660530f53fc4067
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Lymphocytic_T/NK\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	DGKA SIRPG NELL2 NLRC5 THEMIS DOCK8 LTB	3.38e-05	191	209	7	96a7179a845d3daa046ed71fa45c51255f130a7f
ToppCell	Children_(3_yrs)-Epithelial\|Children_(3_yrs) / Lineage, Cell type, age group and donor	ADGRV1 FREM2 ATP13A4 SH3RF1 EPB41L5 ARFGEF3 LRRC36	3.38e-05	191	209	7	e432c6e1ae82dddf84314ce73d2b7a991630d905
ToppCell	COPD-Myeloid-cDC1\|Myeloid / Disease state, Lineage and Cell class	HDAC9 SULF2 SERPINB9 NLRC5 KIF16B LTB MTSS2	3.38e-05	191	209	7	3480e6d27dd4291765bbbb2acdb6a2e4f02c8085
ToppCell	CD8+_Memory_T_cell-CV-7\|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster	PNPT1 DOP1B AHCTF1 HUWE1 NBAS MACF1 PRKDC	3.38e-05	191	209	7	9454f642c3621370fa23640b631301346b300950
ToppCell	facs-Skin\|facs / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	EPHB6 PLBD1 PPP1R13L ITPR3 SERPINB10 LAMB3 SERPINB2	3.38e-05	191	209	7	ae524103331fa53fa82888dbb567fc36abcee7e0
ToppCell	P07-Epithelial-alveolar_epithelial_cell-type_I_pneumocyte\|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	SERPINB9 FRAS1 EPB41L5 LAMB3 RAB11FIP1 TRIM3 SLC4A5	3.38e-05	191	209	7	0f360766490bef3495c42f6421b22a988cfc68fb
ToppCell	10x_3'_v3-tissue-resident_(10x_3'_v3)-myeloid-myeloid_granulocytic\|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	TPSAB1 PADI4 ADGRE2 DYSF TPSD1 TPSB2 ZNF445	3.49e-05	192	209	7	3ce486cd5171f2d04ac4f7f87bead8b0d8c99c17
ToppCell	PCW_07-8.5-Epithelial-Epithelial_proliferating-epi_proliferating3_(5)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	ADGRV1 ITPR3 FREM2 TMEM62 KSR2 LAMB3 LRRC36	3.49e-05	192	209	7	d3634574b2e8d2ded6446969361b70761b331aea
ToppCell	PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell\|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k)	DGKA ESYT2 NELL2 NLRC5 GIMAP6 HSPA8 THEMIS	3.49e-05	192	209	7	1c0ce299cee9ab5cdea256f3e8c1e5598577a8b6
ToppCell	COVID_non-vent-Lymphocytic-T_cell-CD4+_T_cell_(ISG_high)\|COVID_non-vent / Disease condition, Lineage, Cell class and subclass	DGKA ADD3 SIRPG NELL2 HSPA8 THEMIS LTB	3.49e-05	192	209	7	35557254738844c27ffcd00f3287fbcc0a4d0f3b
ToppCell	367C-Myeloid-Dendritic\|Myeloid / Donor, Lineage, Cell class and subclass (all cells)	HDAC9 SULF2 SERPINB9 SERPINF2 UTF1 RAB11FIP1 LTB	3.49e-05	192	209	7	877aaf61d8fc40e7013944a0180306dd0bb0557f
ToppCell	PCW_07-8.5-Epithelial-Epithelial_neuroendo-epi_NE_progenitor_(7)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	ADGRV1 FREM2 ATP13A4 FRAS1 KSR2 LAMB3 ARFGEF3	3.49e-05	192	209	7	b99f8236ef4ccdc75c02abea381cae6453205f6f
Drug	1c5s	TPSAB1 TPSD1 SERPINB2 TPSB2	1.31e-06	10	206	4	CID000444753
Drug	Brunfelsamidine	TPSAB1 TPSD1 TPSB2	2.90e-06	4	206	3	CID005281683
Drug	Erythromycin [114-07-8]; Up 200; 5.4uM; HL60; HG-U133A	EPHB6 SPART URB2 ARHGEF16 NELL2 TMEM62 AP5Z1 LAMA4 ZNF500 MACF1	1.25e-05	196	206	10	2010_UP
Drug	Zardaverine [101975-10-4]; Down 200; 15uM; MCF7; HT_HG-U133A	PPP1R13L DYSF AHDC1 ITPR3 AP5Z1 HPS4 ANAPC2 EXOC7 HSPA2 MYOF	1.25e-05	196	206	10	4793_DN
Drug	Iproniazide phosphate [305-33-9]; Down 200; 14.4uM; PC3; HT_HG-U133A	ANKMY1 PPP1R13L SEMA4C EXOC7 HSPA2 SLC12A6 HDAC5 VEZT L1CAM JHY	1.31e-05	197	206	10	6359_DN
Disease	limb-girdle muscular dystrophy (implicated_via_orthology)	DYSF OTOF MYOF	1.17e-05	7	207	3	DOID:11724 (implicated_via_orthology)
Disease	tryptase beta-2 measurement	TPSAB1 TPSD1 TPSB2	2.77e-05	9	207	3	EFO_0008306
Disease	Visceral myopathy familial external ophthalmoplegia	RRM2B TYMP	4.90e-05	2	207	2	C1848586
Disease	phospholipids:total lipids ratio, high density lipoprotein cholesterol measurement	ASIC2 INHBC DGKQ SULF2 NLRC5 PON3 PRKAG3 ABCA6 DOCK7 MACF1	6.76e-05	307	207	10	EFO_0004612, EFO_0020946
Disease	MITOCHONDRIAL NEUROGASTROINTESTINAL ENCEPHALOPATHY SYNDROME	RRM2B TYMP	1.46e-04	3	207	2	C0872218
Disease	Cryptophthalmos syndrome	FREM2 FRAS1	1.46e-04	3	207	2	C0265233
Disease	FRASER SYNDROME 1	FREM2 FRAS1	1.46e-04	3	207	2	C4551480
Disease	Inherited neuropathies	SPART SACS L1CAM ZFYVE26	1.76e-04	40	207	4	C0598589
Disease	very low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio	INHBC DGKQ SULF2 NLRC5 PRKAG3 ABCA6 DOCK7 MACF1 HTT	2.30e-04	291	207	9	EFO_0008317, EFO_0020946
Disease	Fraser syndrome (implicated_via_orthology)	FREM2 FRAS1	2.91e-04	4	207	2	DOID:0090001 (implicated_via_orthology)
Disease	toll-like receptor 2 measurement	ABCC10 TRIM3	2.91e-04	4	207	2	EFO_0020777
Disease	coronary atherosclerosis measurement	HDAC9 NAV1	4.83e-04	5	207	2	EFO_0007938
Disease	hearing impairment	CDH23 ADGRV1 PNPT1 OTOF MYO15A	6.48e-04	98	207	5	C1384666
Disease	triglycerides:total lipids ratio, low density lipoprotein cholesterol measurement	LACTB PRKAG3 ABCA6 DOCK7 MACF1 HTT	6.86e-04	150	207	6	EFO_0004611, EFO_0020947
Disease	cholesterol to total lipids in medium HDL percentage	INHBC NLRC5 PRKAG3 DOCK7	8.44e-04	60	207	4	EFO_0022237
Disease	recalcitrant atopic dermatitis	THEMIS NBAS	1.00e-03	7	207	2	EFO_1000651
Disease	femoral hernia	PNPT1 SLC30A10	1.00e-03	7	207	2	EFO_1001791
Disease	centronuclear myopathy (implicated_via_orthology)	KLHL31 MTM1	1.00e-03	7	207	2	DOID:14717 (implicated_via_orthology)
Disease	abdominal aortic artery calcification	HDAC9 NAV1	1.00e-03	7	207	2	EFO_0004859
Disease	apolipoprotein A 1 measurement	DGKQ LACTB BTN3A3 TMEM62 SULF2 NLRC5 SLC30A10 HDAC5 ARHGEF25 PRKAG3 ABCA6 SBNO1 DOCK7 MACF1 SMIM44	1.01e-03	848	207	15	EFO_0004614
Disease	Intellectual Disability	TMEM94 KMT2E PNPT1 KMT2C ADSL SACS DOCK8 RRM2B MACF1 HTT	1.31e-03	447	207	10	C3714756
Disease	Unilateral agenesis of kidney	FREM2 FRAS1	1.33e-03	8	207	2	C0266294
Disease	autosomal recessive intellectual developmental disorder (implicated_via_orthology)	CNTNAP3B CNTNAP3	1.33e-03	8	207	2	DOID:0060308 (implicated_via_orthology)
Disease	Colorectal Carcinoma	EPHB6 ESR2 ABCA10 SLC12A5 KMT2C SACS DNAH8 DNAH3 LAMB3 ITPRID1 TYMP ABCA6 VRTN	1.46e-03	702	207	13	C0009402
Disease	urate measurement, bone density	ASIC2 DOCK5 SULF1 ADAMTS16 NAV1 DNAH8 SLC30A10 FRAS1 AHCTF1 HMGXB4 PRKDC JHY	1.51e-03	619	207	12	EFO_0003923, EFO_0004531
Disease	very low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio	INHBC NLRC5 PRKAG3 ABCA6 DOCK7 MACF1 HTT	1.55e-03	239	207	7	EFO_0008317, EFO_0020945
Disease	childhood trauma measurement, alcohol consumption measurement	PCDHGB1 PCDHGA9 KSR2 PCDHGC3	1.58e-03	71	207	4	EFO_0007878, EFO_0007979
Disease	triglycerides to total lipids in small HDL percentage	INHBC NLRC5 PRKAG3 DOCK7	1.67e-03	72	207	4	EFO_0022336
Disease	cholesteryl ester measurement, high density lipoprotein cholesterol measurement	INHBC DGKQ SULF2 NLRC5 KIF16B PON3 PRKAG3 DOCK7	1.70e-03	312	207	8	EFO_0004612, EFO_0010351
Disease	post-operative acute kidney injury	CDH26 CAPRIN1	1.71e-03	9	207	2	EFO_0009955
Disease	Uterine Neoplasms	BAP1 CSF3	1.71e-03	9	207	2	C0042138
Disease	cholesteryl esters:total lipids ratio, high density lipoprotein cholesterol measurement	INHBC LACTB NLRC5 PON3 PRKAG3 DOCK7 MACF1	1.71e-03	243	207	7	EFO_0004612, EFO_0020944
Disease	free cholesterol measurement, high density lipoprotein cholesterol measurement	DGKQ SULF2 NLRC5 KNL1 PON3 PRKAG3 ABCA6 DOCK7	1.80e-03	315	207	8	EFO_0004612, EFO_0008591
Disease	total cholesterol measurement, high density lipoprotein cholesterol measurement	INHBC DGKQ SULF2 NLRC5 KIF16B PON3 PRKAG3 DOCK7	1.80e-03	315	207	8	EFO_0004574, EFO_0004612
Disease	free cholesterol to total lipids in large LDL percentage	PRKAG3 ABCA6 DOCK7 MACF1	1.84e-03	74	207	4	EFO_0022280
Disease	phospholipid measurement, high density lipoprotein cholesterol measurement	INHBC DGKQ SULF2 NLRC5 KNL1 PON3 PRKAG3 DOCK7	2.03e-03	321	207	8	EFO_0004612, EFO_0004639
Disease	Uterine Cancer	BAP1 CSF3	2.12e-03	10	207	2	C0153567
Disease	Developmental delay (disorder)	SPART PNPT1 NBAS	2.22e-03	37	207	3	C0424605
Disease	cortical thickness	HDAC9 ASIC2 ADGRV1 DYSF AFAP1L1 NELL2 SULF2 BPGM NAV1 ABCC10 FNIP2 SYT2 ITIH5 IFTAP DOCK7 MACF1 FIGLA	2.30e-03	1113	207	17	EFO_0004840
Disease	response to vaccine, cytokine measurement	DCHS2 MNAT1 DNAH3 THEMIS SLC4A5	2.36e-03	131	207	5	EFO_0004645, EFO_0004873
Disease	lipid measurement, high density lipoprotein cholesterol measurement	INHBC DGKQ SULF2 NLRC5 KNL1 PON3 PRKAG3 DOCK7	2.40e-03	330	207	8	EFO_0004529, EFO_0004612
Disease	Global developmental delay	TMEM94 SPART KMT2E PNPT1 NBAS	2.52e-03	133	207	5	C0557874
Disease	Hodgkins lymphoma	SERPINF2 THEMIS KIF16B BRME1	2.69e-03	82	207	4	EFO_0000183
Disease	cholesterol in very small VLDL measurement	ABCA10 ABCA6 DOCK7	2.78e-03	40	207	3	EFO_0022231
Disease	Carcinoma, Transitional Cell	ESR2 KMT2C CSF3	2.98e-03	41	207	3	C0007138
Disease	Charcot-Marie-Tooth disease (is_implicated_in)	ITPR3 SLC12A6	3.09e-03	12	207	2	DOID:10595 (is_implicated_in)
Disease	Bladder Neoplasm	ESR2 BAP1 KMT2C TYMP CSF3	3.14e-03	140	207	5	C0005695
Disease	oral microbiome measurement	HDAC9 KMT2C FRAS1	3.19e-03	42	207	3	EFO_0801229
Disease	Malignant neoplasm of urinary bladder	ESR2 BAP1 KMT2C TYMP CSF3	3.24e-03	141	207	5	C0005684
Disease	DEAFNESS, AUTOSOMAL RECESSIVE (disorder)	CDH23 PNPT1	3.63e-03	13	207	2	C1846647
Disease	cholesterol in medium VLDL measurement	ABCA10 ABCA6 DOCK7	3.65e-03	44	207	3	EFO_0022225
Disease	total lipids in very small VLDL measurement	ABCA10 ABCA6 DOCK7	3.89e-03	45	207	3	EFO_0022156
Disease	nevus count, cutaneous melanoma	RTEL1 ADGRV1 DOCK8 SMIM44	3.91e-03	91	207	4	EFO_0000389, EFO_0004632
Disease	neutrophil percentage of leukocytes	HDAC9 CDH23 NLRC5 CRTC3 DOCK8 GTF3C1 CSF3 SBNO1 AKAP11 PRKDC HTT	4.06e-03	610	207	11	EFO_0007990
Disease	Manganese Poisoning	SLC30A10 HTT	4.22e-03	14	207	2	C0677050
Disease	free cholesterol in small VLDL measurement	ABCA10 ABCA6 DOCK7	4.40e-03	47	207	3	EFO_0022272
Disease	free cholesterol in very small VLDL measurement	ABCA10 ABCA6 DOCK7	4.40e-03	47	207	3	EFO_0022275
Disease	free cholesterol in medium VLDL measurement	ABCA10 ABCA6 DOCK7	4.40e-03	47	207	3	EFO_0022269
Disease	autism spectrum disorder (implicated_via_orthology)	CNTNAP3B CNTNAP3 ITPR3 UBE3A TMPRSS9	4.46e-03	152	207	5	DOID:0060041 (implicated_via_orthology)
Disease	Parkinson's disease symptom measurement	PPP1R13L ADGRE2 ADAMTS16	4.67e-03	48	207	3	EFO_0600011
Disease	platelet storage pool deficiency (implicated_via_orthology)	HPS4 DOCK7	4.84e-03	15	207	2	DOID:2223 (implicated_via_orthology)
Disease	very low density lipoprotein cholesterol measurement, cholesterol:total lipids ratio	NLRC5 PRKAG3 ABCA6 DOCK7 MACF1 HTT	4.93e-03	222	207	6	EFO_0008317, EFO_0020943
Disease	cholesteryl esters to total lipids in small VLDL percentage	NLRC5 ABCA6 DOCK7	4.94e-03	49	207	3	EFO_0022256
Disease	Hernia	PNPT1 HMCN2 ADAMTS16	5.53e-03	51	207	3	HP_0100790
Disease	Nonsyndromic Hearing Loss and Deafness, Autosomal Recessive	CDH23 OTOF MYO15A	5.53e-03	51	207	3	cv:CN043650
Disease	phospholipids in very small VLDL measurement	ABCA10 ABCA6 DOCK7	5.53e-03	51	207	3	EFO_0022300
Disease	cholesterol to total lipids in small VLDL percentage	NLRC5 ABCA6 DOCK7	5.53e-03	51	207	3	EFO_0022242
Disease	free cholesterol:total lipids ratio, high density lipoprotein cholesterol measurement	DGKQ SULF2 NLRC5 PON3 PRKAG3 ABCA6 DOCK7	5.74e-03	303	207	7	EFO_0004612, EFO_0020945
Disease	mean platelet volume	HDAC9 ANKMY1 SIRPG DOCK5 ESYT2 GP1BA SLC12A6 HDAC5 PCDHGB1 DOCK8 PCDHGA9 KIF16B DOCK7 PCDHGC3 HTT	5.78e-03	1020	207	15	EFO_0004584
Disease	phospholipids in IDL measurement	ABCA10 ABCA6 DOCK7	5.84e-03	52	207	3	EFO_0022164
Disease	Carcinomatosis	PADI4 ESR2 TYMP CSF3 GLYCAM1	5.97e-03	163	207	5	C0205699
Disease	Carcinoma, Spindle-Cell	PADI4 ESR2 TYMP CSF3 GLYCAM1	5.97e-03	163	207	5	C0205697
Disease	Undifferentiated carcinoma	PADI4 ESR2 TYMP CSF3 GLYCAM1	5.97e-03	163	207	5	C0205698
Disease	Anaplastic carcinoma	PADI4 ESR2 TYMP CSF3 GLYCAM1	5.97e-03	163	207	5	C0205696
Disease	epilepsy (implicated_via_orthology)	SLC12A5 UBE3A SLC12A6 L1CAM SLC1A6	5.97e-03	163	207	5	DOID:1826 (implicated_via_orthology)
Disease	Carcinoma	PADI4 ESR2 TYMP CSF3 GLYCAM1	6.12e-03	164	207	5	C0007097
Disease	cholesterol in small VLDL measurement	ABCA10 ABCA6 DOCK7	6.16e-03	53	207	3	EFO_0022228
Disease	ceramide measurement	HDAC9 ESR2 ANKMY1 MDN1 RRM2B KIF16B	6.46e-03	235	207	6	EFO_0010222
Disease	Peripheral Nervous System Diseases	SLC12A6 CSF3 SERPINB2	6.49e-03	54	207	3	C4721453
Disease	leukemia	KMT2E PPP1R13L BAP1	6.83e-03	55	207	3	C0023418
Disease	hepcidin:ferritin ratio	TMCO5B THEMIS IFTAP	6.83e-03	55	207	3	EFO_0007901
Disease	cystitis (biomarker_via_orthology)	ESR2 CSF3	6.96e-03	18	207	2	DOID:1679 (biomarker_via_orthology)

Protein segments in the cluster

Peptide	Gene	Start	Entry
IDIIQPALVLATGDL	TMEM62	86	Q0P6H9
PVLDVLAALLRQGEE	URB2	1321	Q14146
PGLNGLSDTIILDII	ESYT2	341	A0FGR8
LLDAGIVAELQAPDL	ADCK2	491	Q7Z695
IAPVTLTLGSLLDDQ	CNTNAP3	256	Q9BZ76
ALATGEELPELTLLT	ARHGEF25	111	Q86VW2
EELPELTLLTTLLEG	ARHGEF25	116	Q86VW2
VVSLLLENGADPSLE	ANKRD34C	101	P0C6C1
VVTGPALAEIDLQEL	ANAPC2	781	Q9UJX6
DVILDPDTANAILLV	BTN3A3	341	O00478
LLENTPVLEDVLGRI	CEP68	696	Q76N32
VLSILGNPSVVLLDE	ABCA10	1351	Q8WWZ4
SGLPEDTVLLLLNAI	SERPINF2	221	P08697
SDILQALVLSPAGID	PRKAG3	471	Q9UGI9
LLQDGSPILLSDVIS	ADGRE2	436	Q9UHX3
LVNDQLGLVDSLIPL	BPIFB4	341	P59827
GILPISQESLLLGDV	ADD3	246	Q9UEY8
LILLDGTIQGDPLDL	ATP13A4	536	Q4VNC1
EALESQTLLGPLELV	GSDMD	391	P57764
QTLLGPLELVGSLLE	GSDMD	396	P57764
GITILGDPQILLLDE	ABCA6	626	Q8N139
PGETIQTLLLEVLAD	ADGRV1	2296	Q8WXG9
LPEVVELGILDQLST	ARHGEF16	266	Q5VV41
SQEFPLGIELLLNVL	ANKRD13C	456	Q8N6S4
VVLEVLPLLGRQAES	DGKQ	426	P52824
LELESDPGLFTLLVE	BAP1	6	Q92560
IQDLAAVSLELPDIL	AKAP11	71	Q9UKA4
SLAILDVESGLLPQL	GLYCAM1	16	Q8IVK1
DVESGLLPQLSVLLS	GLYCAM1	21	Q8IVK1
LLQAEDLGPDTLDSL	AP5Z1	31	O43299
VALLPALVDAGTALE	AP5Z1	451	O43299
GLALQALDTLPDSLE	AHDC1	311	Q5TGY3
PDISLLDRDNVGLVL	ANGEL2	276	Q5VTE6
LLEQALELLPGFQEV	CFAP73	146	A6NFT4
GLNGVPILSEEELSL	CAPRIN1	171	Q14444
VLLDEGPDTLNTSLI	CDH23	1641	Q9H251
DLLPLIGSNNVLLEE	ADAMTS14	831	Q8WXS8
GLILLEDEQPGLVIS	ADAMTS16	341	Q8TE57
GELLALLDVNLQIPD	ASIC2	111	Q16515
LIGIDDDLLSTGIIL	KIF16B	456	Q96L93
LEALNRDLVPTGVLV	RABL3	111	Q5HYI8
ENLLRTIELGLEVSP	ISYNA1	246	Q9NPH2
GIDIITALILNDISP	ITPR3	1966	Q14573
GIDTTELLQSLPDEL	KCNH3	551	Q9ULD8
LPEDLAEALASGVIL	LRCH4	556	O75427
ELGLAESDIIDIPQL	PADI4	556	Q9UM07
LSLLVGFLEEGQEPL	ABCC10	306	Q5T3U5
ILLGIPETEGLETAL	OR10D4P	11	Q8NGN7
VDLNDISPLGLATVI	KLHL31	111	Q9H511
VSVLIPLLENGELLI	MDN1	411	Q9NU22
VTILDQEAAGSLILP	FRAS1	3146	Q86XX4
LVEPDGQLILDDSLI	FRAS1	3851	Q86XX4
DELSLVGLPDAIDIQ	KMT2C	226	Q8NEZ4
ELESSDLPVALLLAQ	MNAT1	186	P51948
DALSPEQLVLTLLEA	ESR2	261	Q92731
EESLPEISLLEILQN	JHY	746	Q6NUN7
EAGGQLVIPLDELTL	NEK1	761	Q96PY6
PSLQIDVLTELELGE	NELL2	26	Q99435
ILESAGIASLEVLPL	ITIH5	191	Q86UX2
REGILLQLEVLTAEP	ITPRID1	936	Q6ZRS4
LEVPAELAGLLQAVA	MYO15A	2001	Q9UKN7
PLLTVQEGAVEDLIL	MTO1	146	Q9Y2Z2
LADLSLEISGIIPTD	HMCN2	566	Q8NDA2
GPTLELESQRELLLD	INHBC	31	P55103
ALSLGDVARILEPVL	DOP1B	986	Q9Y3R5
LEEISPGQLSLEDLL	KSR2	106	Q6VAB6
GASSVLLVLPEELDT	LACTB	491	P83111
SLLALLLPLGAVEEQ	FICD	36	Q9BVA6
LPLVVEELLGTSNAL	FREM2	186	Q5SZK8
LVLSLLAEEPLLGDS	HPS4	551	Q9NQG7
VQDLLLLDVTPLSLG	HSPA2	391	P54652
GALTLEQPELVESLS	LRRC36	16	Q1X8D7
ILLGLTNDSELQVPL	OR5B3	11	Q8NH48
LQGIIDDLVVLTAEP	MTSS2	221	Q765P7
DSIPDILADLGSLQI	PCDHGA9	666	Q9Y5G4
ILADLGSLQIPADLE	PCDHGA9	671	Q9Y5G4
QIPEDSDLGTVIALI	PCDHGB1	351	Q9Y5G3
VSDPVLLEILGQASD	DNAH8	1586	Q96JB1
PLDLSNLSLEGIAVL	DGKA	586	P23743
SDLQLGLDAVEPTAL	KMT2E	1021	Q8IZD2
LSLPETETGENLLLI	KNL1	106	Q8NG31
PELEGIEILNSSAVL	L1CAM	816	P32004
EEAERILPGILNDTL	KLHL40	296	Q2TBA0
TINESLLVPLALEID	KRT82	96	Q9NSB4
SLSLLPELTDNGLVA	LRRC29	106	Q8WV35
VLDLSPSRIILGLQD	LRIT3	186	Q3SXY7
VPILLELDENLRAVG	BPGM	216	P07738
NLDLSGLEPILVESD	HMGXB4	281	Q9UGU5
LLLGVTDIQELQPFL	OR12D2	11	P58182
PLGTVIALLSVTDLD	PCDHGC3	366	Q9UN70
RIAQDLGLELAELVP	PCDHA5	46	Q9Y5H7
IFTEQELELLISGLP	HUWE1	4241	Q7Z6Z7
ELELLISGLPTIDID	HUWE1	4246	Q7Z6Z7
PGLLVLCDNLVTLET	NBAS	876	A2RRP1
IENAVESGRALLPIL	PDP1	176	Q9P0J1
LNSVGDLLDLIPSLS	PLBD1	196	Q6P4A8
SPVLILDLISGDDDL	EXOC7	166	Q9UPT5
EVPLDLEVLLLSTFG	NLRC5	81	Q86WI3
PLELLEEATLNVLSA	MACF1	2281	Q9UPN3
STLGLVDVADQPELI	MACF1	2431	Q9UPN3
RLETVALPLQGLEDL	MACF1	4771	Q9UPN3
NVEELRTEGLPLGLI	GRIN3A	361	Q8TCU5
LLLGVTDIQELQPFL	OR12D1	11	P0DN82
NPDLRALTLVEIGIE	DCHS2	2526	Q6V1P9
VILPQVLLGLRDTSD	SCYL3	376	Q8IZE3
IDLLNSPDLLEATIG	EPB41L5	451	Q9HCM4
LEEVEQLLRDLGILP	FHAD1	616	B1AJZ9
LLNVLLGLLVPVEDE	HTT	291	P42858
LLGATEILQADLLPD	IL5RA	11	Q01344
LLLLPGEVEQDVSTS	IFTAP	121	Q86VG3
LLVETLGVPLQEATE	BRME1	146	Q0VDD7
EVLLPLLTDQLSGQL	DOCK5	876	Q9H7D0
LAGLVLTELAVILDP	DOCK7	1186	Q96N67
LTELAVILDPDAEGL	DOCK7	1191	Q96N67
GLLRLEISTAPEIIN	DOCK8	506	Q8NF50
LEVNLEEIPGEGLLI	C2CD2L	191	O14523
LGTPVLIENIGEELD	DNAH3	3121	Q8TD57
LEEELQIEPLSLDGL	CRTC3	581	Q6UUV7
VVLGIESNDLPLLTA	FNIP2	1086	Q9P278
VVLIPGLISGLEEDQ	AVL9	381	Q8NBF6
EGLLPRLLSLSNVEE	ARFGEF3	681	Q5TH69
SGQLPEELFLLLQSL	F8A1;	311	P23610
EQLLVSGQPLLIFLE	GPAT2	276	Q6NUI2
ALPGEEGVQIVELLL	ANKMY1	591	Q9P2S6
ELELQEAELTLPSLG	SLC1A6	526	P48664
LQVDGTLPVLGTLDL	GP1BA	86	P07359
SLEQELQPDLLDSLG	CDH26	801	Q8IXH8
ELGPTLDTLQLDVAD	CSF3	131	P09919
GPELAITLLLAVLTE	DENND4B	406	O75064
TLQGLQLDLPLEEET	LAMB3	661	Q13751
LGEIQVVDAASLLAP	ENGASE	601	Q8NFI3
PEVTLQALGEDEITL	AHCTF1	16	Q8WYP5
ALLGTPQAEVLEDVL	FIGLA	16	Q6QHK4
ALLSVELQPLDEAVL	HDAC5	1021	Q9UQL6
ALLGNELEPLAEDIL	HDAC9	971	Q9UKV0
PLLAEAGDVLELIIS	GRIP2	1006	Q9C0E4
EEELLLLQPELQGGL	PPP1R18	586	Q6NYC8
ELGILIASLDLVAPI	SLC12A6	631	Q9UHW9
NEIEVEGLPLLITLD	SACS	3146	Q9NZJ4
VPLSALELGLETEAA	SBNO1	46	A3KN83
DVSLLSPGEDVLIDI	DYSF	1446	O75923
NPLVLLLDAALTGEL	PPP1R13L	626	Q8WUF5
GLLSPEEDQSLLLSQ	NOC4L	156	Q9BVI4
PSVVLLDDLDLIAGL	PEX1	656	O43933
IAPVTLTLGSLLDDQ	CNTNAP3B	256	Q96NU0
LGLAVEIVDTSNPEL	OTOF	571	Q9HC10
GILIASLDEVAPILS	SLC12A5	571	Q9H2X9
DIEVRTPADNGLILL	LAMA4	1076	Q16363
ENVQDLLLLDVTPLS	HSPA8	386	P11142
LLLPDEIADVSTGLE	SERPINB2	266	P05120
TGIGDVPLVILLDDL	NAV1	1616	Q8NEY1
VPLVILLDDLSEAGS	NAV1	1621	Q8NEY1
GDLLLQQAELPLSTE	FREM3	611	P0C091
ELLLGLLELIEEPSG	GLMN	101	Q92990
ILELQEQLTGLIPSD	RUNDC3A	311	Q59EK9
ILLRLEGAIDAVELP	RTEL1	321	Q9NZ71
LTVGVLQAAELPALD	SYT2	156	Q8N9I0
ALILGENVSLPETLI	UTP20	371	O75691
EGLLSDPLSDLQLVS	RAB11FIP1	931	Q6WKZ4
AQIGADIALLELEEP	TPSAB1	116	Q15661
AQIGADIALLELEEP	TPSB2	116	P20231
GADIALLELEEPVNI	TPSD1	126	Q9BZJ3
DLLVDVLPLVLSRGT	TMCO5B	271	A8MYB1
AVILGDQLTAADLVP	PPP4R1	691	Q8TF05
ELLRSLAEELPLEQG	PLCD4	76	Q9BRC7
EELSQDPVLELSGGL	GIMAP6	16	Q6P9H5
GLILAEILSRLEPVS	IQCA1L	136	A6NCM1
EFLLLGISEEPELQA	OR7A10	11	O76100
AQLSLEDLPALGITL	EPHB6	981	O15197
LAEAEQTLGLPITDE	ADSL	46	P30566
ALPDGLSVEDILNLL	SCG2	426	P13521
ASEGLLNTPDILQLL	SHOC1	871	Q5VXU9
LTNGVLVESLSEEPL	RNF169	601	Q8NCN4
VTLEARAPLENLGLV	SEMA4C	651	Q9C0C4
LLAVDGVNEPDVLAI	PNPT1	156	Q8TCS8
LLTLLLGLTEVAGEE	SIRPG	16	Q9P1W8
TDNLEVILLGLLVPA	SLC10A5	331	Q5PT55
LLGLSDDPDLQIVIF	OR6C3	11	Q9NZP0
LELELTPQGTLAERI	OXCT2	131	Q9BYC2
EELPSNILLVRLLDG	SH3RF1	61	Q7Z6J0
ILDNPTLTLEVLNEA	TGM3	591	Q08188
ELERLAGLEQAILSP	EIF4ENIF1	361	Q9NRA8
VLEQLLPELTGLLSL	AFAP1L1	6	Q8TED9
GLEEELADILQGPSL	CLCN1	961	P35523
IEQEFLTEALPVGLI	RRM2B	261	Q7LG56
AALDLGVQLTPETLV	TNRC18	1241	O15417
LSIEEDVLAATPGLQ	THEMIS	466	Q8N1K5
DDPELVLIVGVLGLL	SLC30A10	111	Q6XR72
LQGVEVALAPEELEL	SF3B2	821	Q13435
LETLGLDADELILIP	SPART	211	Q8N0X7
IPESSELTLQELLGE	UBE3A	401	Q05086
LSPDEQGVDILIVLI	TMPRSS11F	116	Q6ZWK6
ETDSSLILDVPLGVI	MTM1	76	Q13496
NSLLPESGIVADIEL	TFE3	41	P19532
LSLLVLLPDDGVELS	SERPINB9	226	P50453
NLPVSLLVEGDIIAL	TMEM94	176	Q12767
REASPLQSLLEVLGL	SLC39A7	441	Q92504
PLTENSLLEVLDGAV	RNF123	741	Q5XPI4
RPLQTLSLGLEEELL	TMPRSS9	96	Q7Z410
LGPLTEILEGVLQAD	NUP188	1181	Q5SRE5
LDLDSGSLPQIIDDV	SLC4A5	176	Q9BY07
PSLTGEDLEGLDLQL	SMIM44	86	A0A286YF18
LVDNLTVDPATGDIL	PON3	266	Q15166
LLALEPGILDTANVE	VASN	181	Q6EMK4
TVALLEAILDGIVDP	PRKDC	1006	P78527
ELLVLEQFLSILPGE	ZNF445	96	P59923
ELLVLEQFLTVLPGE	ZNF213	86	O14771
EIDGQALLLLTLPTV	SFMBT1	821	Q9UHJ3
LIELLDPSILSAGQS	VEZT	111	Q9HBM0
PVAVLELLQGLESLG	GTF3C1	2031	Q12789
PGLQVLEVDSVALSL	VRTN	51	Q9H8Y1
NIDLAPTILDIAGLD	SULF1	361	Q8IWU6
LLSEDLQGDIPENIL	ZFYVE26	106	Q68DK2
DGTVELVRALPLALV	TYMP	386	P19971
LILLPEDINGLEQLE	SERPINB10	251	P48595
LNIDLAPTILDIAGL	SULF2	361	Q8IWU5
LLTPVLANILEADQE	TBK1	276	Q9UHD2
ELLVLEQFLTVLPGE	ZNF500	91	O60304
EQALRLGSAPEVLLV	TRIM3	256	O75382
ILLSIQSLLGEPNID	UBE2C	131	O00762
RETELLLGTLLQPAV	UTF1	66	Q5T230
ELLLEGAETVTPVLD	LTB	176	Q06643
DDVESNLLLPAGIAL	MYOF	341	Q9NZM1